Bicara Therapeutics Inc. (BCAX)
Healthcare
Biotechnology
27.10 $
+3.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Bicara Therapeutics Inc. (BCAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -38 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -14 | -11 | -8.0 | -15 | -13 | -17 | -30 | -28 | -26 | -29 | -24 | -38 | -116 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.4 | |
| 0.3 | 0.5 | 0.8 | 1.1 | 1.0 | 2.0 | 3.2 | 3.5 | 3.5 | 3.6 | 4.4 | 5.9 | 17 | |
| -0.4 | -1.6 | 2.9 | -3.3 | 3.0 | -1.9 | -12 | 5.1 | -1.9 | 3.2 | 8.4 | 12 | 22 | |
| 0.0 | 0.2 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.1 | 0.3 | |
| – | -0.2 | -0.4 | 0.1 | 0.0 | 0.0 | 0.0 | – | – | -236 | -82 | 101 | – | |
| 19 | 40 | 195 | 0.1 | 0.7 | 334 | -1.0 | 0.5 | 0.1 | 0.4 | 31 | 163 | 195 | |
| 15 | 29 | 186 | -14 | 204 | 317 | -31 | -28 | -25 | -265 | -75 | 227 | -139 | |
| -14 | -11 | -8.5 | -15 | -13 | -17 | -30 | -28 | -26 | -29 | -24 | -38 | -117 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.